Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The UNIVERSITY OF SOUTH AUSTRALIA is currently managing 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 6 distinct examiners, which indicates that each pending matter is being reviewed by a different individual. This distribution suggests a range of examiner perspectives are currently being applied to the university's patent applications.
The portfolio's active matters are situated within 3 distinct art units, showing that the university's research in this technology area spans multiple specialized examination groups. ARNOLD, ERNST V is the busiest examiner with 1 pending office action. Given that the busiest examiner pending count is 1 and there are 6 pending office actions in total, the workload is evenly divided among the 6 distinct examiners assigned to the university's files.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §102 only | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARNOLD, ERNST V | 1 | 48.2% | +12.9% |
| KLIMOWICZ, WILLIAM JOSEPH | 1 | 80.9% | +18.2% |
| CABRAL, ROBERT S | 1 | 62.6% | +32.5% |
| VILLANUEVA, MARKUS ANTHONY | 1 | 58.7% | +32.4% |
| NGO, MEAGAN N | 1 | 58.3% | +33.1% |
| HERON, VELVET ELIZABETH | 1 | 47.4% | +52.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568250 | IMPROVEMENTS IN OPTICAL DATA STORAGE | KLIMOWICZ, WILLIAM JOSEPH | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18873222 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | ARNOLD, ERNST V | — |
| 18240743 | NANOPARTICLE CANCER THERAPY | CABRAL, ROBERT S | — |
| 18011003 | A DATA PROCESSING METHOD | VILLANUEVA, MARKUS ANTHONY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18873222 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | ARNOLD, ERNST V | — |
| 18568250 | IMPROVEMENTS IN OPTICAL DATA STORAGE | KLIMOWICZ, WILLIAM JOSEPH | — |
| 18240743 | NANOPARTICLE CANCER THERAPY | CABRAL, ROBERT S | — |
| 18011003 | A DATA PROCESSING METHOD | VILLANUEVA, MARKUS ANTHONY | — |
| 18052988 | PLASMA HYDROGEL THERAPY | NGO, MEAGAN N | — |
| 17774078 | Pumpless Microfluidic Devices and Uses Thereof | HERON, VELVET ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| 3781 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18873222 | COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF | ARNOLD, ERNST V | — | §102§103§112 | Non-Final OA | — | Pending | Dec 09, 2024 |
| 18568250 | IMPROVEMENTS IN OPTICAL DATA STORAGE | KLIMOWICZ, WILLIAM JOSEPH | — | §103 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18240743 | NANOPARTICLE CANCER THERAPY | CABRAL, ROBERT S | 1618 | §102§103§112 | Non-Final OA | — | Pending | Aug 31, 2023 |
| 18011003 | A DATA PROCESSING METHOD | VILLANUEVA, MARKUS ANTHONY | — | §103§112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 18052988 | PLASMA HYDROGEL THERAPY | NGO, MEAGAN N | 3781 | §102 | Final Rejection | — | Pending | Nov 07, 2022 |
| 17774078 | Pumpless Microfluidic Devices and Uses Thereof | HERON, VELVET ELIZABETH | 1798 | §103 | Non-Final OA | — | Pending | May 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial